三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

First mpox vaccine candidate begins trials

By ZHOU WENTING in Shanghai | China Daily | Updated: 2025-04-10 09:00
Share
Share - WeChat

China's first mpox vaccine candidate has begun Phase I clinical trials, the Shanghai Institute of Biological Products Co said on Tuesday.

Medical experts said the vaccine could play a crucial role in preventing and controlling mpox in China and beyond.

The company, a subsidiary of China National Biotec Group, said trials of the MVA strain mpox attenuated live vaccine are underway at Henan Infectious Diseases Hospital in Zhengzhou, Henan province.

Designed for people age 18 and older at high risk for mpox, the vaccine trials aim to enroll 120 participants in Zhengzhou, including 60 healthy individuals, 30 men who have sex with men and 30 people living with HIV.

The National Medical Products Administration, China's top drug regulator, approved the vaccine for clinical trials in September, making it the country's first mpox vaccine candidate to enter the clinical stage.

In China, vaccine candidates typically undergo three phases of clinical trials before receiving market approval, a process that can take years. However, regulatory authorities have launched accelerated channels to expedite applications for novel drugs and vaccines in urgent demand.

The new vaccine is a replication-deficient vaccine based on a modified vaccinia Ankara (MVA) strain, similar to Jynneos, the world's first mpox vaccine, developed by Danish company Bavarian Nordic.

Preclinical studies showed the vaccine candidate was safe and generated immune protection against the mpox virus in primate models, the company said.

"We will fully cooperate to ensure the smooth progress of the clinical trials and accelerate the follow-up transformation work of the vaccine, striving for marketing soon and contributing to mpox prevention in China and globally," Li Xiuling, general manager of the Shanghai Institute of Biological Products, said at a meeting at the Henan hospital in January.

Mpox is a viral zoonotic disease caused by the mpox virus and spreads through direct contact, respiratory droplets, contaminated items, and mother-to-child and sexual transmissions. Its clinical features resemble smallpox, though with milder symptoms and a lower mortality rate of 1 to 10 percent.

The WHO issued temporary guidelines for mpox vaccinations in August 2022, recommending them for close contacts of mpox patients and high-risk groups, including men who have sex with men, people with multiple sexual partners and healthcare workers at risk of exposure.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产在线观看高清精品 | 国产特级毛片aaaaaa | 国产色婷婷精品综合在线 | 亚洲综合色网 | 成年美女黄网站色视频大全免费 | 欧美一级毛片一 | 又爽又黄又无遮挡的视频美女软件 | 欧美三级欧美做a爱 | 一级在线观看视频 | 黄色影院免费 | 欧美换爱交换乱理伦片不卡片 | 国产h在线观看 | 免费播放国产性色生活片 | 亚洲最大看欧美片网站 | 国产一级黄色毛片 | 欧美成综合网网站 | 亚洲一区免费在线 | 草草草在线视频 | 色综合综合色 | 五十路一区二区三区视频 | 特黄特色视频 | 国产在线不卡一区 | 欧美日韩在线成人看片a | 性网站在线 | 中文字幕精品一区二区日本大胸 | 在线观看的黄色网址 | 国产理论自拍 | 久久东京伊人一本到鬼色 | 无码一区二区三区视频 | 日本韩国欧美在线观看 | 一级片免费在线 | 激情一区二区三区成人 | 国产麻豆视频免费观看 | 亚洲精品一区二区四季 | 国产一二三区在线观看 | 成人女人a毛片在线看 | 青草草视频在线观看 | 一区二区三区四区在线不卡高清 | 亚洲在线视频 | 一级a毛片| 国产97在线观看 |